CELLPHIRE

Cellphire is actively seeking partners within industry and academia to evaluate applications for stabilized cellular therapies in a wide range of clinical, therapeutic, and diagnostic fields... Through our veterinary subsidiary, BodeVet®, we developed and launched the company's first commercially available product, StablePlate RX® Canine, a canine freeze-dried platelet product with demonstrated efficacy in stopping bleeding in dogs. We are developing additional innovative transfusion medicine therapies for companion animals, including freeze-dried canine plasma. BodeVet® is also expanding its platelet work to support equine patients, as well as exotic animals such as elephants... Cellphire has 2 products in clinical trials, CLPH-211 a Freeze-dried Platelet-derived Hemostat (FPH) for use in hospital operating rooms and CLPH-511, our Cryopreserved Platelet (CPP) Operating Room (OR) product. We believe the FPH hemostatic technology can address efficacy, safety, and availability needs..

Also known as: Cellphire Therapeutics, Inc., Cellphire, Inc.

Primary location: Rockville United States